Jiangsu GDK Biotechnology Co Ltd 688670.SS

Last Updated: May 15, 12:00 AM·SSE

Jiangsu GDK Biotechnology Co Ltd

Jiangsu GDK Biotechnology Co Ltd. Stock Analysis 688670.SS

China Health Care Small Cap
Jiangsu gdk Biotechnology Co., Ltd. engages in the research and development, production and sale of human vaccines. The company is headquartered in Taizhou, Jiangsu and currently employs 390 full-time employees. The company went IPO on 2021-08-02. The Company’s products mainly include human vaccines for the prevention of infectious diseases such as influenza, rabies, chickenpox, shingles, and pneumonia. The firm mainly operates its businesses in the domestic market.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.